We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 25

DAMITT Q2 2016 Update: Antitrust Merger Investigation Duration and Activity Remain Near Record Levels; New Analysis Shows Merger Litigation Is Taking Longer, Too
  • Dechert LLP
  • USA
  • July 14 2016

Significant merger investigations during the first half of 2016 lasted 9.5 months on averageon par with CY2015, but more than 30 percent longer than


The Impact of Brexit on Global M&A: Perspectives from the UK, US and Europe
  • Dechert LLP
  • European Union, Global, United Kingdom, USA
  • July 13 2016

The British public voted to leave the European Union on Thursday 23 June. What happens next is far from certain. The implications for global M&A


Dechert Antitrust Merger Investigation Timing Tracker Reports Record Duration and Number of U.S. Merger Investigations in 2015
  • Dechert LLP
  • USA
  • January 7 2016

Significant antitrust merger investigations in the United States took an average of 9.6 months in 2015, more than a third longer than the average just two years ago, according to DAMITT


FTC report shows that oil sector and pharmaceutical sector mergers are under the antitrust spotlight
  • Dechert LLP
  • USA
  • January 22 2013

The U.S. Federal Trade Commission ("FTC") issued a data report on January 4 regarding its horizontal merger investigation and enforcement action


Recent proposed regulations regarding accountable care organizations (ACOs) and their potential impact on deal activity
  • Dechert LLP
  • USA
  • April 21 2011

One of the most heralded creations of last year's Patient Protection and Affordable Care Act (PPACA) was the Medicare Shared Savings Program for Accountable Care Organizations (ACOs


Can strategic partner antitrust risk management cash-free deal for PE buyer?
  • Dechert LLP
  • USA
  • December 13 2010

Managing antitrust risk historically has not been regarded as an essential skill for private equity buyers



Adam Martin
  • Dechert LLP

Eric S. Siegel
  • Dechert LLP